List of Global DOP Substitute Companies Serbia

  • List of Global DOP Substitute Companies Serbia
  • List of Global DOP Substitute Companies Serbia
  • List of Global DOP Substitute Companies Serbia
  • How can Serbian pharmaceutical companies benefit from global trends?
  • Serbian pharmaceutical companies have strategically positioned themselves to benefit from global trends in the industry. Companies such as Hemofarm and Galenika, which have invested significant capital in development, expand the borders of medicine in the region.
  • Who makes Genezis in Serbia?
  • Serbia is the home to Galenika a.d and Hemofarm a.d. (STADA Group), one of the largest manufacturing pharmaceutical companies in Serbia, with a presence in 30 countries. They manufacture both OTC and prescription medicines. Genezis is an association of generic and biosimilar drug makers in Serbia and Montenegro.
  • How big is the pharmaceutical industry in Serbia?
  • The industry and pharmaceutical companies in Serbia have an estimated market size of €833 million, with an expected growth of 6.7% from 2019 to 2021. Prescription medications account for the majority of sales well ahead of 0TC drugs.
  • Which public companies have lost the most money in Serbia?
  • The company that generated the biggest losses is Elektroprivreda Srbije (EPS). Other public enterprises that recorded the biggest losses include Roads of Serbia (JP Putevi Srbije), GSP Beograd (Belgrade public transport company), JP PEU Resavica (mining company) and JP Elektrokosmet (power company).
  • How is the manufacture and trade of drugs regulated in Serbia?
  • The manufacture and trade of drugs and other pharmaceutical products are regulated by the Drugs and Health Products Act (in force since August 1, 2004). With this law, the Agency for Medicines and Health Products of Serbia was established to bring national regulations into line with EU standards.

Recommended hot-selling products